BLUE Shares Outstanding History



Below is a table of the BLUE shares outstanding history going back to 6/19/2013:

Date BLUE Shares Outstanding
6/19/201333.77M
7/29/201336.63M
10/31/201336.72M
2/24/201437.32M
5/8/201437.85M
7/29/201444.15M
11/6/201444.50M
2/18/201550.28M
4/28/201550.69M
7/31/201555.99M
10/30/201556.63M
2/18/201657.02M
4/30/201657.04M
7/29/201657.39M
10/28/201657.60M
2/17/201763.06M
4/28/201763.23M
7/28/201770.39M
10/27/201770.76M
2/16/201877.17M
4/27/201877.38M
7/27/201883.62M
10/26/201884.45M
2/15/201984.84M
4/26/201985.11M
7/25/201985.34M
10/25/201985.43M
2/13/202085.86M
5/5/202085.93M
7/31/2020102.25M
10/30/2020102.48M
2/18/2021103.67M
4/30/2021104.14M
8/3/2021104.34M
11/1/2021108.25M
2/28/202271.43M
5/4/202271.45M
8/3/202277.12M
11/3/202282.91M
3/27/2023106.37M
5/5/2023106.41M
8/4/2023106.95M
11/3/2023109.34M

Also see: BLUE Market Cap History
BLUE YTD Return
BLUE Historical Shares Outstanding:
+11.98% CAGR
BLUE Historical Shares Outstanding: +11.98% CAGR

Mouse over chart for data details
6/19/2013 ...11/3/2023
bluebird bio is a biotechnology company focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector gene addition platform. Co. has two gene therapies: ZYNTEGLO® (betibeglogene autotemcel, also known as beti-cel) and SKYSONA® (elivaldogene autotemcel, also known as eli-cel). ZYNTEGLO is for the treatment of adult and pediatric patients with B-thalassemia who require regular red blood cell transfusions. SKYSONA is for slowing the progression of neurologic dysfunction in boys four to 17 years of age with early active cerebral adrenoleukodystrophy. We show 43 historical shares outstanding datapoints in our coverage of BLUE's shares outstanding history.

Understanding the changing numbers of BLUE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BLUE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BLUE by allowing them to research BLUE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree BLUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
bluebird bio (BLUE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BMEA Shares Outstanding History
BMRA Shares Outstanding History
BMRN Shares Outstanding History
BMY Shares Outstanding History
BNGO Shares Outstanding History
BNTC Shares Outstanding History
BOLD Shares Outstanding History
BOLT Shares Outstanding History
BPMC Shares Outstanding History
BPTH Shares Outstanding History
More Healthcare companies »

 

BLUE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.